Physician Wealth Advisors’s Axsome Therapeutics AXSM Stock Holding History

Physician Wealth Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.22K	Sell	12 -5	-29%	-$1.09K	﹤0.01%	1521
2026 Q2	$4.18K	Buy	17 +2	+13%	+$434	﹤0.01%	1178
2026 Q1	$2.55K	Buy	15 +3	+25%	+$518	﹤0.01%	1246
2025 Q4	$2.2K	Buy	12 +2	+20%	+$279	﹤0.01%	1242
2025 Q3	$1.22K	Sell	10 -4	-29%	-$451	﹤0.01%	1455
2025 Q2	$1.47K	Buy	14 +4	+40%	+$424	﹤0.01%	1172
2025 Q1	$1.17K	Hold	10	–	–	﹤0.01%	987
2024 Q4	$852	Buy	+10	New	+$920	﹤0.01%	978

Other funds holding AXSM

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return

M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return

HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return

Iridian Asset Management Westport, Connecticut $275M AUM 37.66% 1-Year Est. Return

Physician Wealth Advisors's AXSM Position: Q3 2026 in Review

Physician Wealth Advisors reduced its Axsome Therapeutics (AXSM) stake by 29% in Q3 2026, selling an estimated $1.09K and leaving 12 shares worth $2.22K. The position accounts for ﹤0.01% of the portfolio, ranked #1521.

Physician Wealth Advisors first reported a position in AXSM in Q4 2024 and has held it in 8 quarters since. The position peaked at $4.18K in Q2 2026. 146 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

Physician Wealth Advisors held 12 shares of Axsome Therapeutics worth $2.22K as of Q3 2026.
Physician Wealth Advisors sold 5 Axsome Therapeutics shares in Q3 2026, an estimated $1.09K.
Axsome Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #1521 holding.
Physician Wealth Advisors first reported a position in Axsome Therapeutics in Q4 2024 and has held it in 8 quarters since.
Physician Wealth Advisors's Axsome Therapeutics position peaked at $4.18K in Q2 2026.
146 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.